Cargando…
重组人血小板生成素在成人原发免疫性血小板减少症患者围手术期的应用
OBJECTIVE: To evaluate the efficacy and safety of recombinant human thrombopoietin (rhTPO) treatment for primary immune thrombocytopenia (ITP) patients during the perioperative period. METHODS: Adult ITP patients who were refractory to first-line glucocorticoid therapy and underwent selective surger...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342530/ https://www.ncbi.nlm.nih.gov/pubmed/30929384 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.03.005 |
Ejemplares similares
-
重组人血小板生成素治疗92例成人重型原发免疫性血小板减少症的临床观察
Publicado: (2015) -
重组人血小板生成素治疗41例儿童原发免疫性血小板减少症的疗效及安全性
Publicado: (2015) -
重组人血小板生成素用于原发免疫性血小板减少症维持治疗的有效性和安全性——多中心临床研究
Publicado: (2017) -
大剂量地塞米松联合重组人血小板生成素治疗48例成人初治重症原发免疫性血小板减少症的有效性及安全性
Publicado: (2016) -
重组人血小板生成素联合激素及环孢素A治疗免疫相关性血细胞减少症20例近期疗效及安全性
Publicado: (2017)